Eastwood Bio-Medical Canada Inc

TSXV:EBM (Canada)  
C$ 0.54 (0%) Dec 24
At Loss
Market Cap:
C$ 37.20M ($ 25.84M)
Enterprise V:
C$ 37.25M ($ 25.88M)
Volume:
-
Avg Vol (2M):
2.02K
Trade In:

Business Description

Description
Eastwood Bio-Medical Canada Inc is a Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The company is engaged in natural health supplement distribution company. It has its geographic presence in U.S., Canada and Asia. The company generates maximum revenue from Asia.
Name Current Vs Industry Vs History
Cash-To-Debt 0.2
Equity-to-Asset -3.45
Debt-to-Equity -0.06
Debt-to-EBITDA -0.18
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -17.2
Distress
Grey
Safe
Beneish M-Score -8.84
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 9.1
3-Year EBITDA Growth Rate 18.3
Name Current Vs Industry Vs History
5-Day RSI 17.26
9-Day RSI 26.52
14-Day RSI 33.65
6-1 Month Momentum % 25
12-1 Month Momentum % 36.36

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.05
Quick Ratio 0.05
Cash Ratio 0.01
Days Sales Outstanding 16.55
Days Payable 161.07

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 0.01
Name Current Vs Industry Vs History
Gross Margin % 62.18
Operating Margin % -68.91
Net Margin % -74.12
FCF Margin % -0.77
ROA % -117.59
ROIC % -115.56
ROC (Joel Greenblatt) % -148.91

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 54
EV-to-EBIT -80.28
EV-to-EBITDA -104.34
EV-to-Revenue 57.04
EV-to-FCF -7450
Price-to-Median-PS-Value 0.95
Earnings Yield (Greenblatt) % -1.25
FCF Yield % -0.01

Financials

TSXV:EBM's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Eastwood Bio-Medical Canada Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0.653
EPS (TTM) (C$) -0.03
Beta -0.38
Volatility % 114.06
14-Day RSI 33.65
14-Day ATR (C$) 0.040241
20-Day SMA (C$) 0.6995
12-1 Month Momentum % 36.36
52-Week Range (C$) 0.28 - 1.15
Shares Outstanding (Mil) 68.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Eastwood Bio-Medical Canada Inc Filings

Filing Date Document Date Form
No Filing Data

Eastwood Bio-Medical Canada Inc Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Eastwood Bio-Medical Canada Inc Frequently Asked Questions

What is Eastwood Bio-Medical Canada Inc(TSXV:EBM)'s stock price today?
The current price of TSXV:EBM is C$0.54. The 52 week high of TSXV:EBM is C$1.15 and 52 week low is C$0.28.
When is next earnings date of Eastwood Bio-Medical Canada Inc(TSXV:EBM)?
The next earnings date of Eastwood Bio-Medical Canada Inc(TSXV:EBM) is .
Does Eastwood Bio-Medical Canada Inc(TSXV:EBM) pay dividends? If so, how much?
Eastwood Bio-Medical Canada Inc(TSXV:EBM) does not pay dividend.

Press Release

Subject Date
No Press Release